Rallybio Stockholders Approve Avenzo Merger, Name Change and Reverse Split

Rallybio stockholders approved proposals tied to the company's planned merger with Avenzo Therapeutics, including issuing Rallybio shares to Avenzo security holders. The approved corporate actions would take effect in connection with the transaction; the article gives no merger completion date or financial terms.